Cellebrite DI Ltd. (CLBT)
NASDAQ: CLBT
· Real-Time Price · USD
18.62
-0.14 (-0.77%)
At close: Oct 03, 2025, 3:59 PM
18.75
0.70%
After-hours: Oct 03, 2025, 07:28 PM EDT
-0.77% (1D)
| Bid | 18.46 |
| Market Cap | 4.55B |
| Revenue (ttm) | 436.73M |
| Net Income (ttm) | -150.95M |
| EPS (ttm) | -0.71 |
| PE Ratio (ttm) | -26.23 |
| Forward PE | 46.91 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 19.25 |
| Volume | 808,540 |
| Avg. Volume (20D) | 1,910,069 |
| Open | 18.80 |
| Previous Close | 18.77 |
| Day's Range | 18.59 - 18.95 |
| 52-Week Range | 13.10 - 26.30 |
| Beta | 1.29 |
| Ex-Dividend Date | n/a |
About CLBT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CLBT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CLBT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsCellebrite DI Ltd. is scheduled to release its earnings on
Nov 5, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+9.29%
Cellebrite shares are trading higher after the com...
Unlock content with
Pro Subscription
4 months ago
-11.48%
Cellebrite DI shares are trading lower after the company reported mixed Q1 financial results and cut its FY25 sales guidance with its midpoint below estimates. Also, the company issued Q2 sales guidance with its midpoint below estimates.
